Decoy Therapeutics, Inc.

CAMBRIDGE, MA · CIK 0002065438 · Biotech · Public

Peptide conjugate therapeutics engineered for targeted drug delivery

decoytx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.0M
1 Form D · Apr 2025
17 months since last filing
Contracts
—
No federal contracts on record
Patents
21
1 granted · 20 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,020,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2567Ichor Microbial Solutions, Inc.—$1.1M
2568WAYPATH PHARMA LLC——
2569SENEX BIOTECHNOLOGY, INC.—$1.0M
2570Decoy Therapeutics, Inc.—$1.0M
2571NEW HORIZON BIOTECH INC——
2572AMPLION INC.—$1.0M
2573Biosceptre International Ltd—$1.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Barbara HibnerDirector · Executive Officer
  • Michael LippExecutive Officer
  • Peter MarschelDirector · Executive Officer
  • Frederick PierceDirector · Executive Officer

Patents

USPTO · 1 granted of 21
  • Anti-Viral Therapeutic Peptides, Conjugates, and Methods of Use Thereofapplication
  • Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmissionapplication
  • Methods and Compositions for Treating Infectionsapplication
  • Methods And Compositions For Treating Infectionsgranted
  • Methods And Compositions For Treating Covid Infectionsapplication
  • Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmissionapplication
  • Methods For Making Peptide Conjugates And The Product Made Therefromapplication
  • Formulation of Antiviral Peptide Conjugatesapplication
  • Anti-viral Therapeutic Peptides, Conjugates, And Methods Of Use Thereofapplication
  • Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmissionapplication
  • Methods And Compositions For Treating Covid Infectionsapplication
  • Methods and Compositions for Treating Infectionsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.